R-CHOP has not only led to a marked improvement of survival in DLBCL but has also called into question the significance of the IPI [5], leading to introduction of the revised IPI (R-IPI) [6]. The gene discussed is DDIT3; the disease is diffuse large B-cell lymphoma.